非凡中國(08032.HK)首季純利跌96.7%至2703.1萬港元
格隆匯5月12日丨非凡中國(08032.HK)公佈,2020年第一季度,集團實現收益9238.8萬港元,同比下降48.2%;毛利1705萬港元,同比下降9.0%;公司權益持有人應占溢利2703.1萬港元,同比下降96.7%;基本每股盈利0.24港仙。
公告稱,收益減少乃主要由於企業策略作出若干調整,期內縮減建材業務。而利潤下滑乃主要由於期內並無出售一間聯營公司的部分權益而產生的任何收益。於2019年第一季度,出售李寧公司全部已發行股本6.8%產生出售一間聯營公司的部分權益的收益8.17億港元。
值得一提的是,集團現時預期相關業務可能會隨着內地疫情受到控制後在第二季逐漸回覆正常。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.